Penny Stocks

Is Pharmacyte Biotech a Boiler Room Stock?

When investing in disruptive technologies, it is important to be able to identify investments you should not invest in along with those that may show promise. In the disruptive technology space, you will come across three types of companies; startups or private companies which often show the most promise but hold their cards close to […]

It May Be a Bad Idea to Invest in Solar Power Inc.

Grid parity is what is referred to as solar-generated electricity that is equal to or cheaper than retail electricity prices. According to a recent report by Deutsche Bank, we are already at grid parity in more than half of all countries, and within two years will be at parity in around 80% of countries. This in part […]

Sigma Labs Continues to Disappoint Investors

Our readers know how we feel about over the counter (OTC) companies. Countless OTC companies have lost investors’ money over the years and while there may be the rare exception, you won’t find the next Microsoft on the OTC exchange. We will continue to call out companies that are long on promises and press releases […]

Can Principal Solar Become A Solar Utility?

In previous articles, we’ve discussed how investors should avoid over-the-counter companies at all costs. With rare exceptions, 99% of the time long term investors who buy into the promises of OTC companies will end up losing their investments in the long run. Whether with malicious intent or not, the management of these companies will often […]

Manhattan Scientifics and Senior Scientific

In a previous article, we highlighted Manhattan Scientific (OTCMKTS:MHTX),  a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields, with emphasis in the areas of nanotechnology. The Company has two focuses: a nanostructured metals technology (Metallicum), and a nanoparticle-based technology that provides highly sensitive cancer detection (Senior Scientific). We already covered […]

Manhattan Scientifics and Metallicum’s Nanometals

Who is Manhattan Scientifics? Manhattan Scientifics (OTCMKTS:MHTX) is a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields, with emphasis in the areas of nanotechnology. They are currently focused on two opportunities: a nanostructured metals technology (Metallicum), and a nanoparticle-based technology that provides highly sensitive cancer detection (Senior Scientific). MHTX trades as […]

Solar3D: Just Another Californian Solar Installer?

In past articles, we’ve highlighted the dangers of over-the-counter (OTC) stocks, especially those that seem to attach themselves to up and coming disruptive technologies. Such companies need to be subjected to detailed scrutiny as the majority of OTC companies will lose investors’ money over time. Whether through intent or not, company management always seems to […]

Regen Biopharma IPO: Buyer Beware

Around 6 months ago we published an article titled “Big Red Flags from Bio-Matrix and Regen Biopharma“. Any investor who would have sold their shares in Bio-Matrix (OTCMKTS:BMSN) the Monday after our article was published would have been fortunate. Those who did not sell their shares would have lost -61% of their investment as of today. […]

3D Graphtech: Another 3D Printing Graphene Company

3D printing has the potential for very high growth in the coming years. Graphene is an amazing material that has many potential disruptive applications. Combine the two and you get 3DG; 3D Printing using graphene. Graphene 3D Labs, a company with several patent applications and $1.3 million in cash has managed to increase their share […]

Will Sigma Labs Finally Deliver on Their Promises?

In past articles, we discussed an over-the-counter (OTC) 3D Printing company called Sigma Labs (OTCMKTS:SGLB), a company that while popular among 3D Printing speculators, has shown many red flags over time. In particular, the company announced marketing and partnership agreements with entities of which no information could be found, sold 22% of the company for […]